BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26152007)

  • 1. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA.
    Gönenç G; Işçi H; Yiğiter AB; Hançer V; Büyükdoğan M; Güdücü N; Dünder I
    Clin Exp Obstet Gynecol; 2015; 42(3):344-6. PubMed ID: 26152007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
    Clausen FB; Barrett AN;
    Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
    Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
    Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
    de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
    BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prenatal diagnosis and determination of fetal Rh status.
    van der Schoot CE; Hahn S; Chitty LS
    Semin Fetal Neonatal Med; 2008 Apr; 13(2):63-8. PubMed ID: 18249590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non invasive detection of fetal Rh using real-time PCR method].
    Lázár L; Nagy B; Bán Z; Nagy GR; Beke A; Papp Z
    Orv Hetil; 2007 Mar; 148(11):497-500. PubMed ID: 17350921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
    Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
    Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
    Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of fetal RhD gene from maternal blood.
    Günel T; Kalelioğlu I; Ermiş H; Aydınlı K
    J Turk Ger Gynecol Assoc; 2010; 11(2):82-5. PubMed ID: 24591904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.
    Finning K; Martin P; Summers J; Massey E; Poole G; Daniels G
    BMJ; 2008 Apr; 336(7648):816-8. PubMed ID: 18390496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-invasive fetal RhD typing and RhD negative pregnant women--preliminary observations].
    Guz K; Brojer E; Zupańska B; Orzińska A; Kalińska A; Bec JR
    Ginekol Pol; 2004 Jan; 75(1):21-5. PubMed ID: 15112469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of conventional hemi nested PCR analysis for fetal RHD determination in maternal plasma].
    Dif-Couvreux D; Houfflin-Debarge V; Delsalle A; Dourieux S; Dubreucq S; Manessier L; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2006 Nov; 35(7):658-64. PubMed ID: 17088765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
    Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR
    Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.